Skip to content

Deep Neuromuscular Block on Cytokines Release and Postoperative Delirium

The Effect of Deep Neuromuscular Block on Cytokines Release and Postoperative Delirium of Elderly Patients Undergoing Total Hip Arthroplasty

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02507609
Enrollment
82
Registered
2015-07-24
Start date
2015-09-08
Completion date
2018-04-26
Last updated
2018-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Fractures

Brief summary

The purpose of the study is to determine the relationship between the degree of neuromuscular block, the release of cytokines and clinical outcomes in elderly patients undergoing orthopedic surgery. Investigators hypothesize that deep neuromuscular blockade decreases the release of cytokine and the incidence of postoperative delirium in elderly patients undergoing orthopedic surgery, compared with moderate neuromuscular blockade.

Detailed description

* Study design \- This is a prospective, randomized, single blinded study. * Measurement values * Neuromuscular monitoring by post-tetanic count (PTC) during operation * Regional cerebral oxygen saturation monitoring * Mean systemic blood pressure (MBP), heart rate (HR) * Cardiac index (CI), using non-invasive cardiac output monitor * IL-1ß, IL-6, TNF-α, IL-10 and CRP * Arterial blood gas analysis (ABGA) * Laboratory values \[Hemoglobin, Hematocrit, serum albumin, creatinine, CPK, LDH\] * Postoperative pain, using visual analogue scale (VAS) * Postoperative nausea and vomiting (PONV) * Total infused amounts of drugs * Total anesthesia duration, intubation duration and operation duration * Intubation duration, operation duration * Incidence of postoperative intensive care unit (ICU) admission * Total ICU staying duration, if patients admit to ICU * Preoperative and postoperative left ventricular ejection fraction change * Incidence of hypotension (mean blood pressure lesser than 60 mmHg) * Incidence of postoperative delirium using confusion assessment method (CAM) intensive care unit (ICU) * Total amount of blood products transfusion (paced red blood cells, fresh frozen plasma, platelet concentration, cryoprecipitate) * Total amount of crystalloids and colloids infusion * Total amount urine output

Interventions

TOF count is maintained to 1 to 2 by intermittent intravenous injection of rocuronium bromide 5 mg during operation

PTC is maintained to 1 to 2 degree by continuous infusion of rocuronium bromide intravenous route

Sponsors

Konkuk University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All adult (more than 50 years old) patients scheduled for total hip arthroplasty and total knee arthroplasty who have signed the written informed consent.

Exclusion criteria

* Inability to give informed consent * Preexisting cognitive dysfunction or delirium * Known allergy to rocuronium sugammadex * Underlying liver dysfunction (AST and ALT more than 100 IU/l) * Underlying kidney dysfunction (Serum Creatinine more than 1.5 mg/dl) * Underlying neuromuscular disease * Patients taking any medication with potential interference with neuromuscular transmission

Design outcomes

Primary

MeasureTime frame
Interleukin 6postoperative 4 hours

Secondary

MeasureTime frameDescription
postoperative deliriumup to postoperative day 7The incidence of postoperative delirium will be assessed by using confusion assessment method (CAM)

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026